This article was published in ISPOR Value and Outcomes Spotlight
Michele Pistollato and Charlotte Capdevila co-authored an article in the latest ISPOR VOS Spotlight issue developed in collaboration with Oriana Ciani, Ramiro Gilardino, and Tilman Krueger. The analysis focuses on European countries and aims to provide a comprehensive overview of the benefits of innovative medicines in early-stage cancers, assess current challenges to patient access to such treatments, and identify key policy solutions to overcome those challenges.
